Congress has passed a continuing resolution (CR) that will fund the government through November 17, 2023, temporarily avoiding a shutdown and giving lawmakers more time to negotiate critical funding decisions for Fiscal Year (FY) 2024.

The CR continues FY 2023 funding for the National Institutes of Health (NIH) and the National Cancer Institute (NCI). The Association for Clinical Oncology (ASCO) is calling on Members of Congress to work together to achieve a bipartisan FY24 federal funding bill and to support cancer research with robust, sustained, and predictable funding for the NIH and NCI.

For FY 2024, ASCO is asking Congress to provide $51 billion for the NIH, $9.988 billion for the NCI, and to designate $1.5 billion for the Advanced Research Projects Agency for Health (ARPA-H).

Join ASCO and urge your lawmakers to support cancer research. To send a letter directly to your members of Congress, visit the ACT Network.